← Leaderboards
Dawn Irene Velligan
University Of Texas Hlth Sci Ctr San Ant
$11,942,798
Attributed
$11,942,798
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$11,942,798 · 7
By mechanism
R01$10,578,794 · 5
R56$767,263 · 1
R34$596,741 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Sci Ctr San Ant
Same institution · by research overlap
- Kelly J Hunt$9,165,512
- Jacques G Baillargeon$307,924
Others in their field
Top investigators on “Schizophrenia”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$104,668,216
- Raquel E Gur · University Of Pennsylvania$60,189,770
- Mark J Daly · Broad Institute, Inc.$48,989,393
- John M Kane · Long Island Jewish Medical Center$45,235,871
- Carrie E Bearden · University Of California Los Angeles$42,025,230
- Scott W Woods · Yale University$41,221,536
Research focus
SchizophreniaTrainingAntipsychotic AgentsCognitiveHome EnvironmentPsychosocialRandomizedPharmaceutical PreparationsSymptomsBypassCostDirect CostsAdaptive BehaviorsCommunitiesRecoveryBaseFunctional OutcomesCuesDesignAttentionPersonsMemoryCognitive FunctionCognitive Behavior Therapy
Grant awards (29)
Cognitive Adaptation Training: Effectiveness in real-world settings and Mechanisms of Action (CAT-EM)$418,144
R01 · FY2022 · MH · contact PI
Cognitive Adaptation Training: Effectiveness in real-world settings and Mechanisms of Action (CAT-EM)$546,504
R01 · FY2021 · MH · contact PI
Remote Cognitive Adaptation Training to improve medication follow through in managed care (R-CAT)$767,263
R56 · FY2020 · MH · contact PI
Cognitive Adaptation Training: Effectiveness in real-world settings and Mechanisms of Action (CAT-EM)$541,374
R01 · FY2020 · MH · contact PI
Cognitive Adaptation Training: Effectiveness in real-world settings and Mechanisms of Action (CAT-EM)$617,001
R01 · FY2019 · MH · contact PI
Cognitive Adaptation Training: Effectiveness in real-world settings and Mechanisms of Action (CAT-EM)$609,717
R01 · FY2018 · MH · contact PI
Treatment Development Targeting Severe and Persistent Negative Symptoms$161,460
R34 · FY2013 · MH · contact PI
Intervention to Improve Functional Outcome & Persistent Symptoms in Schizophrenia$373,814
R01 · FY2012 · MH · contact PI
Treatment Development Targeting Severe and Persistent Negative Symptoms$234,806
R34 · FY2012 · MH · contact PI
Interventions to Improve Functional Outcome and Persistent Symptoms in Schizophre$504,001
R01 · FY2011 · MH · contact PI
Treatment Development Targeting Severe and Persistent Negative Symptoms$200,475
R34 · FY2011 · MH · contact PI
Interventions to Improve Functional Outcome and Persistent Symptoms in Schizophre$518,124
R01 · FY2010 · MH · contact PI
Interventions for Adherence to Oral Antipsychotic Medications in Schizophrenia$405,258
R01 · FY2010 · MH · contact PI
Interventions to Improve Functional Outcome, Persistent Symptoms in Schizophrenia$512,543
R01 · FY2009 · MH · contact PI
Interventions for Adherence to Oral Antipsychotic Medications in Schizophrenia$468,771
R01 · FY2009 · MH · contact PI
Interventions to Improve Functional Outcome, Persistent Symptoms in Schizophrenia$545,654
R01 · FY2008 · MH · contact PI
Interventions for Adherence to Oral Antipsychotic Medications in Schizophrenia$463,545
R01 · FY2008 · MH · contact PI
Interventions for Adherence to Oral Antipsychotic Medications in Schizophrenia$462,453
R01 · FY2007 · MH · contact PI
Interventions for Adherence to Oral Antipsychotic Medications in Schizophrenia$445,397
R01 · FY2006 · MH · contact PI
Compensating for Cognitive Deficits in Schizophrenia$305,000
R01 · FY2005 · MH
MEDICATION ADHERENCE AND OUTCOMES IN SCHIZOPHRENIA$402,745
R01 · FY2004 · MH
Compensating for Cognitive Deficits in Schizophrenia$305,000
R01 · FY2004 · MH
MEDICATION ADHERENCE AND OUTCOMES IN SCHIZOPHRENIA$305,000
R01 · FY2003 · MH
Compensating for Cognitive Deficits in Schizophrenia$305,000
R01 · FY2003 · MH
Compensating for Cognitive Deficits in Schizophrenia$305,000
R01 · FY2002 · MH
MEDICATION ADHERENCE AND OUTCOMES IN SCHIZOPHRENIA$305,000
R01 · FY2002 · MH
MEDICATION ADHERENCE AND OUTCOMES IN SCHIZOPHRENIA$305,000
R01 · FY2001 · MH
Compensating for Cognitive Deficits in Schizophrenia$304,340
R01 · FY2001 · MH
MEDICATION ADHERENCE AND OUTCOMES IN SCHIZOPHRENIA$304,409
R01 · FY2000 · MH